Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-08-006679
Filing Date
2008-12-03
Accepted
2008-12-03 17:32:14
Documents
1
Period of Report
2008-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 2855
  Complete submission text file 0001005477-08-006679.txt   4786
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address C/O PROTEIN DESIGN LABS 34801 CAMPUS DR FREMONT CA 94555 4018420755
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 081228290